A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Crohn's Disease

In brief

The purpose of this study is to determine whether Daikenchuto(TU-100)is effective in the treatment of Crohn's disease.

Key facts

Study ID
NCT01388933
Run by
Tsumura USA
People needed
79
Starts
2011-09-01
Expected to finish
2013-09-01
Last updated by the study team
2015-06-11

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.